|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [654]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [654]
The distinction of positive and negative symptoms. The failure of a two-dimensional model. British Journal of Psychiatry, 158, 317–322.
Arndt, S., Andreasen, N. C., Flaum, M., Miller, D., & Nopoulos, P. (1995). A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Archives of General Psychiatry, 52, 352–360.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212–1213.
Arsenault, L., Cannon, M., Witton, J., & Murray, R. (2003). The causal association between cannabis and psychosis: An examination of the evidence. British Journal of Psychiatry.
Asarnow, J. R. (1994). Annotation: childhood—onset schizophrenia. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 35, 1345–1371.
Asarnow, J. (1988). Children at risk for schizophrenia: Converging lines of evidence. Schizophrenia Bulletin, 14, 613–631.
Asarnow, J. R., Tompson, M. C., & Goldstein, M. J. (2001). Psychosocial factors: The social context of child and adolescent-onset schizophrenia. In H. Remschmidt (Ed.), Schizophrenia in children and adolescents (pp. 168–181). Cambridge, UK: Cambridge University Press.
Asarnow, J. R., Tompson, M., Hamilton, E. B., Goldstein, M. J., & Guthrie, D. (1994). Family-expressed emotion, childhood-onset depression, and childhood-onset schizophrenia spectrum disorders: Is expressed emotion a non-specific correlate of child psychopathology or a specific risk factor for depression? Journal of Abnormal Child Psychology, 22, 129–146.
Asarnow, R. (1983). Schizophrenia. In R. Tartar (Ed.), The child at psychiatric risk (pp. 150–194). New York: Oxford University Press.
Asarnow, R. F., Nuechterlein, K. H., Fogelson, D., Subotnik, K. L., Payne, D. A., Russell, A. T., et al. (2001). Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia:
The UCLA family study. Archives of General Psychiatry, 58, 581–588.
Asarnow, R., Steffy, R., MacCrimmon, D., & Cleghorn, J. (1978). An attentional assessment of foster children at risk for schizophrenia. In L. Wynne, R. Cromwell, & S. Matthysse (Eds.), The nature of schizophrenia: New approaches to research and treatment (p. 356). New York: John Wiley & Sons.
Asarnow, R., Tanguay, P., Bott, L., & Freeman, B. (1987). Patterns of intellectual functioning in non-retarded autistic and schizophrenic children. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 28, 273–280.
Aylward, E., Walker, E., & Bettes, B. (1984). Intelligence in schizophrenia: Meta-analysis of the research. Schizophrenia Bulletin, 10, 430–459.
Barbee, J. G., Mancuso, D. M., Freed, C. R., & Todorov, A. A. (1992). Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. American Journal of Psychiatry, 149, 506–510.
Baribeau-Braun J., Picton T., & Gosselin J. (1983). Schizophrenia: A neurophysiological evaluation of abnormal information processing. Science, 219, 874–876.
Battaglia, J., Moss, S., Rush, J., Kang, J., Mendoza, R., Leedom, L., et al. (1997). Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. American Journal of Emergency Medicine, 15, 335–340.
Beck, A. T., Sokol, L., Clark, D. A., Berchick, R., & Wright, F. (1992). A crossover study of focused cognitive therapy for panic disorder. American Journal of Psychiatry, 149, 778–83.
Bellack, A. S., & Brown, S. A. (2001). Psychosocial treatments for schizophrenia. Current Psychiatry Reports, 3, 407–412.
Bellack, A. S., & Mueser, K. T. (1993). Psychosocial treatment for schizophrenia. Schizophrenia Bulletin, 19, 317–336.
Bentsen, H. (2003). Correspondence. Psychological Medicine, 33, 755.
end p.654
|
|
|
|
